4/25/2012 Link Joseph F. Finn, Jr. C.P.A. to speak at Massachusetts BioTech Council: Finance & More ...
|
3/17/2011 Bankruptcy Insider The Deal 03_17_11.pdf Bay State Bedrock Joseph Finn has carved a niche for himself in Massachusetts AB More ...
|
12/8/2009 Primary Press Release 12_08_09.pdf Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platfo More ...
|
4/2/2009 Primary Press Release 12_08_09a.pdf Finn, Warnke & Gayton: Non Legal Estate Wrap-up
|
3/17/2009 Link Assignment for the Benefit of Creditors: Evaluating the Option of an ABC? Boston More ...
|
8/22/2008 Link Joseph Finn on the ABCs of Biotech Liquidation: Beware of Collusion! by Ryan McB More ...
|
6/27/2013 Link Finding riches in entrepreneurs' woes Commentary: Specialists see opportunity as More ...
|
9/15/1999 Link CHANGING DIRECTIONS IN MID-STREAM: LESSONS TO BE LEARNED FROM REPOSITIONING YOUR More ...
|
1/1/1968 Philosophical Notions On The Problem Of Accounting Principles JFF_1968.pdf Some Philosophical Notions On The Problem Of Accounting Principals by Joseph F. More ...
|
6/19/2008 ActivBiotics 06_19_08.pdf ActivBiotics Assignee Issues First Distribution of Cash to Creditors
|
4/2/2008 ActivBiotics 04_02_08.pdf ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, S More ...
|
3/5/2008 ActivBiotics 3_14_08.pdf ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, More ...
|
2/19/2008 ActivBiotics 02_19_08.pdf ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superio More ...
|
1/28/2008 ActivBiotics 01_28_08.pdf ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative fo More ...
|
1/15/2008 ActivBiotics 01_15_08.pdf ActivBiotics Extends Deadline to March 14, 2008 for the Sale of Proprietary As More ...
|
12/18/2007 ActivBiotics 12_18_07.pdf ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates
|
12/7/2007 ActivBiotics Inc. Assigns Assets to Joseph F. Finn, Jr. C.P.A. for the Benefit o More ...
|
12/8/2011 AFBC EPIX Pharmaceutical Auction for S1P1 Assets - all assets sold
|
11/29/2011 Epix 11_29_11.pdf AMG 277 Discriminates Against S1P3 Receptor by 50-fold.
|
11/17/2011 Epix 11_17_11.pdf AMG 369 Discriminates Against S1P3 Receptor by 296-Fold
|